News Headlines

  1. Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts

    New facility will create 200 new jobs and accelerate commercialization of gene and cell therapies.

  2. Fujifilm Establishes The Bio Science & Engineering Laboratories U.S.A. To Start Full-Scale Translational Research For Biotherapeutics In The United States

    FUJIFILM Corporation (President: Kenji Sukeno) announced that it has begun full-scale research activities to advance the field of translational research for biotherapeutics at its newly established “Bio Science & Engineering Laboratories U.S.A.”

  3. VGXI Selects BE&K As Design Firm For New 240,000 Square Foot Manufacturing Facility

    VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, announces it has chosen the integrated construction services company BE&K Building Group as Design-Build Partner for the initial phase of its new manufacturing site.

  4. Boehringer Ingelheim Chooses NiceLabel Solution To Help Support Standardized Labeling Worldwide

    Global pharmaceutical company, Boehringer Ingelheim, has selected NiceLabel, a leading global developer of label design software and label management systems, to help it create a global standardized labeling process.

  5. Astellas Buys Audentes Therapeutics For $3B For Gene Therapy Drug Manufacturing Expansion

    Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Audentes Therapeutics, Inc. (Chairman and CEO: Matthew R. Patterson, “Audentes”), today announced that they have entered into a definitive agreement for Astellas to acquire Audentes at a price of US$60.00 per share in cash, representing a total equity value of approximately US$3B.

  6. Speeding Cell, Gene Therapy Development

    An innovative new major private-public partnership led by Harvard and MIT aims to accelerate one of the hottest and most promising areas of medical research: cell and gene therapy

  7. Heraeus Expands Cancer Therapy API Capacity

    Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients (Pt HPAPIs) with an additional production line built at the company’s headquarters in Hanau, Germany.

  8. WuXi Vaccines To Build A $240M Manufacturing Facility In Ireland

    WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in human vaccine Contract Development and Manufacturing Organization (CDMO) business, is to invest 240 million USD and build a new vaccine manufacturing facility in Ireland.

  9. AstraZeneca Partnership Gives Significant Boost To Sun Pharma’s Overall China Entry Strategy, Says GlobalData

    Sun Pharmaceutical Industries Ltd (Sun Pharma) has recently entered into a licensing agreement with AstraZeneca UK to launch novel ready-to-use oncology drugs in China.

  10. Navrogen Inc. And Lonza Sign Agreement To Use Lonza’s GS Gene Expression System For Navrogen’s Anti-HIO Targeting Agents

    Navrogen Inc. and Lonza Pharma & Biotech announced today that they have entered a licensing agreement for the production of Navrogen biotherapeutics using Lonza’s GS Xceed Expression System.